In 9 clinical trials, children received either amoxicillin or cotrimoxazole for different durations.
Nineteen people have contracted Legionella-related pneumonia involving both lungs, and 6 have died.
A cluster of 10 illnesses and 3 deaths is linked to a healthcare facility in the northern part of the country.
Antibiotic resistance, one of the most common causes of community-acquired pneumonia (CAP) in children, has risen dramatically over the past two decades, according to a study published this week in JAMA Network Open.
A study of children hospitalized with community-acquired pneumonia (CAP) suggests that antibiotic decisions made in the emergency department (ED) have a significant impact on inpatient antibiotic use, researchers reported today in Pediatrics.
The study also found that nearly a third of children without radiographic evidence of pneumonia received antibiotics, suggesting that overuse is common.
The shortened approach achieved a similar clinical response and resolution of symptoms.
Antibiotic prescribing in general practice in England fell significantly during the first 12 months of the COVID-19 pandemic compared with the previous year, according to data released last week by Antibiotic Research UK (ANTRUK).
Among children with community-acquired pneumonia (CAP) who were discharged from the hospital within 48 hours but required further outpatient treatment, a lower dose of oral amoxicillin was non-inferior to a higher dose, and a 3-day duration was non-inferior to 7 days, according to the results of a randomized clinical trial published today in JAMA.
A study of preterm newborns in Canada found high rates of antimicrobial use in the first 7 days after birth, researchers reported last week in Infection Control & Hospital Epidemiology.
Antibiotic-resistant blood infection in pediatric pneumonia patients was tied to a 17-fold mortality risk.
